TY  - JOUR
AU  - Pulido Ortega, Federico
AU  - Rubio García, Rafael
AU  - Gatel, José M.
PY  - 2004
DO  - 10.1097/00126334-200404010-00003
SN  - 1525-4135
UR  - https://hdl.handle.net/20.500.14352/107282
T2  - Acquired Immune Deficiency Syndrome
AB  - Objective: To compare the clinical, immunologic, and virologic outcomes of efavirenz (EFV)-based versus protease inhibitor (PI)-based highly active antiretroviral therapy (HAART) in severely immunosuppressed HIV-1-infected patients.Design:...
LA  - eng
M2  - 343
PB  - Lippincott Williams & Wilkins, Inc.
KW  - HIV
KW  - efavirenz
KW  - protease inhibitor
KW  - antiretroviral-naive patients
KW  - advanced HIV infection
TI  - Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)
TY  - journal article
VL  - 35
ER  -